Alliance A081105 (Non-Small Cell Lung Cancer) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to compare the standard treatment with standard treatment plus the study drug erlotinib to see which one is better.
Non-Small Cell Lung Cancer
Who Can Participate in the Study?
Adults with non-small cell lung cancer who:
- Have completely resected non-squamous non-small cell lung cancer
- Have no history of cornea abnormalities
- Are not pregnant or nursing
What is Involved?
If you choose to join this study, you will:
- Be randomized (like the flip of a coin) and get either:
-- Group 1: The study drug erlotinib for up to 2 years
-- Group 2: Observation; will not get erlotinib but will be followed by their study doctor
-- Get a CT scan and clinic visits every 6 months for the first 4 years and then yearly for the following 6 years for up to 10 years from the start of the study